Literature DB >> 29067741

Synthetic liver function is detectable in transgenic porcine livers perfused with human blood.

Arielle Cimeno1, Beth M French1, Jessica M Powell1, Carol Phelps2, David Ayares2, Natalie A O'Neill1, Christopher T Laird1, Richard N Pierson1, Agnes M Azimzadeh1, Rolf N Barth1, John C LaMattina1.   

Abstract

In addition to immune barriers, molecular incompatibilities between species are predicted to limit pig liver survival in primate xenotransplantation models. Assessment and measurement of synthetic function of genetically modified porcine livers after ex vivo perfusion with human blood have not previously been described. Eight porcine livers from α1,3-galactosyl transferase knockout and human membrane cofactor (GalTKO.hCD46), six livers from GalTKO.hCD46 and N-glycolylneuraminic acid knockout (GalTKO.hCD46.Neu5GcKO), and six livers from GalTKO.hCD46 with humanized decay-accelerating factor (hCD55), endothelial protein C receptor (hEPCR), tissue factor pathway inhibitor (hTFPI), and integrin-associated protein (hCD47) (GalTKO.hCD46.hCD55.hEPCR.hTFPI.hCD47) pigs were perfused with human blood under physiologic conditions. Timed blood samples were tested for liver enzymes and for pig-specific albumin production via Western blot. Porcine albumin levels increased with time in all experiments. By densitometry, GalTKO.hCD46.Neu5GcKO livers had the highest albumin levels, measured both as total produced, and when controlled for perfusion duration, compared to GalTKO.hCD46 (P = .068) and GalTKO.hCD46.hCD55.hEPCR.hTFPI.hCD47 livers (P = .04). Porcine livers perfused with human blood demonstrated the synthetic ability to produce albumin in all cases. GalTKO.hCD46.Neu5GcKO pig livers demonstrated the most robust albumin production. This suggests that the Neu5GcKO phenotype provides a protective effect on the graft due to decreased human antibody recognition and graft injury.
© 2017 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  liver xenotransplantation; synthetic function; transgenic pigs

Mesh:

Substances:

Year:  2017        PMID: 29067741      PMCID: PMC5809179          DOI: 10.1111/xen.12361

Source DB:  PubMed          Journal:  Xenotransplantation        ISSN: 0908-665X            Impact factor:   3.907


  20 in total

1.  A Bridge to Somewhere: 25-day Survival After Pig-to-Baboon Liver Xenotransplantation.

Authors:  Jigesh A Shah; Nalu Navarro-Alvarez; Matthew DeFazio; Ivy A Rosales; Nahel Elias; Heidi Yeh; Robert B Colvin; A Benedict Cosimi; James F Markmann; Martin Hertl; David H Sachs; Parsia A Vagefi
Journal:  Ann Surg       Date:  2016-06       Impact factor: 12.969

2.  Evaluation of human and non-human primate antibody binding to pig cells lacking GGTA1/CMAH/β4GalNT2 genes.

Authors:  Jose L Estrada; Greg Martens; Ping Li; Andrew Adams; Kenneth A Newell; Mandy L Ford; James R Butler; Richard Sidner; Matt Tector; Joseph Tector
Journal:  Xenotransplantation       Date:  2015-03-01       Impact factor: 3.907

Review 3.  Controlling coagulation dysregulation in xenotransplantation.

Authors:  Peter J Cowan; Simon C Robson; Anthony J F d'Apice
Journal:  Curr Opin Organ Transplant       Date:  2011-04       Impact factor: 2.640

4.  Pig kidney graft survival in a baboon for 136 days: longest life-supporting organ graft survival to date.

Authors:  Hayato Iwase; Hong Liu; Martin Wijkstrom; Huidong Zhou; Jagjit Singh; Hidetaka Hara; Mohamed Ezzelarab; Cassandra Long; Edwin Klein; Robert Wagner; Carol Phelps; David Ayares; Ron Shapiro; Abhinav Humar; David K C Cooper
Journal:  Xenotransplantation       Date:  2015-06-29       Impact factor: 3.907

5.  Prolonged Survival Following Pig-to-Primate Liver Xenotransplantation Utilizing Exogenous Coagulation Factors and Costimulation Blockade.

Authors:  J A Shah; M S Patel; N Elias; N Navarro-Alvarez; I Rosales; R A Wilkinson; N J Louras; M Hertl; J A Fishman; R B Colvin; A B Cosimi; J F Markmann; D H Sachs; P A Vagefi
Journal:  Am J Transplant       Date:  2017-06-06       Impact factor: 8.086

6.  The synthesis rates of total liver protein and plasma albumin determined simultaneously in vivo in humans.

Authors:  H Barle; B Nyberg; P Essén; K Andersson; M A McNurlan; J Wernerman; P J Garlick
Journal:  Hepatology       Date:  1997-01       Impact factor: 17.425

Review 7.  Experimental hepatocyte xenotransplantation--a comprehensive review of the literature.

Authors:  Huidong Zhou; Hong Liu; Mohamed Ezzelarab; Eva Schmelzer; Yi Wang; Jörg Gerlach; Bruno Gridelli; David K C Cooper
Journal:  Xenotransplantation       Date:  2015-05-07       Impact factor: 3.907

8.  Production of alpha 1,3-galactosyltransferase-deficient pigs.

Authors:  Carol J Phelps; Chihiro Koike; Todd D Vaught; Jeremy Boone; Kevin D Wells; Shu-Hung Chen; Suyapa Ball; Susan M Specht; Irina A Polejaeva; Jeff A Monahan; Pete M Jobst; Sugandha B Sharma; Ashley E Lamborn; Amy S Garst; Marilyn Moore; Anthony J Demetris; William A Rudert; Rita Bottino; Suzanne Bertera; Massimo Trucco; Thomas E Starzl; Yifan Dai; David L Ayares
Journal:  Science       Date:  2002-12-19       Impact factor: 47.728

9.  Impact of thrombocytopenia on survival of baboons with genetically modified pig liver transplants: clinical relevance.

Authors:  B Ekser; C Long; G J Echeverri; H Hara; M Ezzelarab; C C Lin; M E de Vera; R Wagner; E Klein; R F Wolf; D Ayares; D K C Cooper; B Gridelli
Journal:  Am J Transplant       Date:  2009-12-23       Impact factor: 8.086

10.  N-glycolylneuraminic acid knockout reduces erythrocyte sequestration and thromboxane elaboration in an ex vivo pig-to-human xenoperfusion model.

Authors:  Arielle Cimeno; Wessam Hassanein; Beth M French; Jessica M Powell; Lars Burdorf; Olga Goloubeva; Xiangfei Cheng; Dawn M Parsell; Jagdeece Ramsoondar; Kasinath Kuravi; Todd Vaught; Mehmet C Uluer; Emily Redding; Natalie O'Neill; Christopher Laird; Alena Hershfeld; Ivan Tatarov; Kathryn Thomas; David Ayares; Agnes M Azimzadeh; Richard N Pierson; Rolf N Barth; John C LaMattina
Journal:  Xenotransplantation       Date:  2017-09-22       Impact factor: 3.907

View more
  2 in total

Review 1.  A review of pig liver xenotransplantation: Current problems and recent progress.

Authors:  Xuan Zhang; Xiao Li; Zhaoxu Yang; Kaishan Tao; Quancheng Wang; Bin Dai; Shibin Qu; Wei Peng; Hong Zhang; David K C Cooper; Kefeng Dou
Journal:  Xenotransplantation       Date:  2019-02-15       Impact factor: 3.907

2.  Human erythrocyte fragmentation during ex-vivo pig organ perfusion.

Authors:  Zahra A Habibabady; Selin Sendil; Felix Ellett; Franziska Pollok; Gabriela F Elias; Beth M French; Wenji Sun; Gheorghe Braileanu; Lars Burdorf; Daniel Irimia; Richard N Pierson; Agnes M Azimzadeh
Journal:  Xenotransplantation       Date:  2022-02-02       Impact factor: 3.907

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.